Divergent regional patterns of cerebral hypoperfusion and gray matter atrophy in mild cognitive impairment patients
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Reductions of cerebral blood flow and gray matter structure have been implicated in early pathogenesis of Alzheimer’s disease, potentially providing complementary information. The present study evaluated regional patterns of cerebral hypoperfusion and atrophy in patients with mild cognitive impairment and healthy older adults. In each participant, cerebral perfusion and gray matter structure were extracted within selected brain regions vulnerable to Alzheimer’s disease using magnetic resonance imaging. Measures were compared between diagnostic groups with/without adjustment for covariates. In mild cognitive impairment patients, cerebral blood flow was significantly reduced in comparison with healthy controls in temporo-parietal regions and the basal ganglia in the absence of local gray matter atrophy. By contrast, gray matter structure was significantly reduced in the hippocampus in the absence of local hypoperfusion. Both, cerebral perfusion and gray matter structure were significantly reduced in the entorhinal and isthmus cingulate cortex in mild cognitive impairment patients compared with healthy older adults. Our results demonstrated partly divergent patterns of temporo-parietal hypoperfusion and medial-temporal atrophy in mild cognitive impairment patients, potentially indicating biomarker sensitivity to dissociable pathological mechanisms. The findings support applicability of cerebral perfusion and gray matter structure as complementary magnetic resonance imaging-based biomarkers in early Alzheimer’s disease detection, a hypothesis to be further evaluated in longitudinal studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0694-180 · Cited by 1,920 · cited 1×
“In the MCI group, APOE "2 carriers were excluded, given the protective role of APOE "2 in AD pathology(27) and AD risk.(28) The study was approved by the Ethics Committee of the Charité University Hospital, Berlin, Germany and was in accordance with the Declaration of Helsinki.”
MethodWinkler, A. M., Kochunov, P., Blangero, J., Almasy, L., Zilles, K., Fox, P. T., Duggirala, R., & Glahn, D. C. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.12.028 · Cited by 1,172 · cited 1×
“Volume is influenced by both surface area and cortical thickness, but appears to be more closely related to surface area.(37) For each ROI, volume was determined using the FSL software and the non-zero voxels combined for the left and right hemisphere.”
MethodAPOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging
Morris, J. C., Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., & Mintun, M. A. (2010) · Annals of Neurology · doi:10.1002/ana.21843 · Cited by 830
Reiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., Ayutyanont, N., Keppler, J., Reeder, S. A., Langbaum, J. B. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900345106 · Cited by 785 · cited 1×
“For the present analysis, only apolipoprotein E (APOE) "4 non-carriers were included in the HC group, to minimize the possibility of AD pathology associated with APOE "4-related genetic risk.(17) In the MCI group, APOE "2 carriers were excluded, given the protective role of APOE "2 in AD pathology(27) and AD risk.”
MethodKhan, U. A., Liu, L., Provenzano, F. A., Berman, D. E., Profaci, C. P., Sloan, R., Mayeux, R., Duff, K. E., & Small, S. A. (2014) · Nature Neuroscience · doi:10.1038/nn.3606 · Cited by 561
The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia
Iadecola, C. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0718-6 · Cited by 557 · cited 2×
“Cerebrovascular pathology and vascular risk factors may also be involved in neurovascular dysfunction and atrophy.(3) In the present study, we could not identify a major role of vascular pathology.”
BackgroundLinking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis
Small, S. A., & Duff, K. (2008) · Neuron · doi:10.1016/j.neuron.2008.11.007 · Cited by 546 · cited 1×
“Medial-temporal atrophy, as seen in the hippocampus and entorhinal regions, has been linked to tau pathology in AD patients,(50,55) thought to emerge through at least partly independent pathological pathways.(56) Given that local pathological processes may affect distant functionally connected brain regions, it is als…”
Background
Cited by
Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease
Kisler, K., Nelson, A. R., Montagne, A., & Zlokovic, B. V. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.48 · Cited by 1,243
The role of brain vasculature in neurodegenerative disorders
Sweeney, M. D., Kisler, K., Montagne, A., Toga, A. W., & Zlokovic, B. V. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0234-x · Cited by 998
Vascular dysfunction—The disregarded partner of Alzheimer's disease
Sweeney, M. D., Montagne, A., Sagare, A. P., Nation, D. A., Schneider, L. S., Chui, H. C., Harrington, M. G., Pa, J., Law, M., Wang, D. J. J., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.07.222 · Cited by 711
“CBF reductions are detected by several different imaging methods, including pseudo-continuous ASL-MRI [17,28,33–37,41,50–52], four-dimensional phase contrast angiography [53], dynamic susceptibility-contrast (DSC) MRI [38], single-photon emission computed tomography [30–32,54], TCD [55], perfusion computed tomography…”
InfluentialSalminen, A., Kauppinen, A., & Kaarniranta, K. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13932 · Cited by 205
“The reduction in glucose metabolism displayed a more global pattern than the changes observed in CBF, although there appeared to be hypoperfused areas in the frontal lobes which did not display evidence of hypometabolism.”
BackgroundInfluentialWang, Z., Williams, V. J., Stephens, K. A., Kim, C., Bai, L., Zhang, M., & Salat, D. H. (2020) · Human Brain Mapping · doi:10.1002/hbm.24871 · Cited by 28
Metadata
- Authors
- Wirth, M., Pichet Binette, A., Brunecker, P., Köbe, T., Witte, A. V., & Flöel, A.
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2016-07-20
- Volume
- 37
- Issue
- 3
- Pages
- 814-824
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W2333603017
- Cited by
- 51
- References
- 17
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Divergent regional patterns of cerebral hypoperfusion and gray matter atrophy in mild cognitive impairment patients. https://app.cochat.ai/papers/10.1177/0271678x16641128
- The paper
- Wirth, M., Pichet Binette, A., Brunecker, P., Köbe, T., Witte, A. V., & Flöel, A. (2017). Divergent regional patterns of cerebral hypoperfusion and gray matter atrophy in mild cognitive impairment patients. Journal of Cerebral Blood Flow & Metabolism. https://doi.org/10.1177/0271678x16641128
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.